MARKET

AVXL

AVXL

Anavex Life Scie
NASDAQ
3.805
-0.115
-2.93%
Opening 15:15 12/18 EST
OPEN
3.980
PREV CLOSE
3.920
HIGH
4.080
LOW
3.790
VOLUME
1.33M
TURNOVER
--
52 WEEK HIGH
14.44
52 WEEK LOW
2.860
MARKET CAP
339.97M
P/E (TTM)
-6.9971
1D
5D
1M
3M
1Y
5Y
1D
Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's
Seeking Alpha · 3h ago
Anavex Life Sciences Requests European Medicines Agency To Re-Examine Its Opinion On Blarcamesine For Treatment Of Early Alzheimer's Disease
Benzinga · 8h ago
Anavex submits request for EMA to re-examine its opinion on blarcamesine
TipRanks · 8h ago
ANAVEX LIFE SCIENCES CORP - REQUESTS EMA TO RE-EXAMINE BLARCAMESINE FOR ALZHEIMER'S
Reuters · 8h ago
Anavex Life Sciences Requests EMA Re-Examination of Alzheimer's Drug Blarcamesine
Reuters · 8h ago
Promising Therapeutic Potential of Blarcamesine Sparks Buy Rating for Anavex Life Sciences
TipRanks · 1d ago
Anavex participates in a conference call with H.C. Wainwright
TipRanks · 2d ago
Anavex Life Sciences Is Maintained at Buy by D. Boral Capital
Dow Jones · 3d ago
More
About AVXL
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with high unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which it uses in the analysis of its clinical trials. Its focus is on developing treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other CNS disorders. It has two core programs and two seed programs. ANAVEX 2-73 is being developed as an oral liquid once-daily formulation for rare diseases such as Rett syndrome as well as an oral once-daily capsule formulation for diseases such as Alzheimer’s disease. ANAVEX 3-71 is a CNS-penetrable potential disease-modifying treatment for cognitive impairments. Its other candidates include ANAVEX 1-41, ANAVEX 1066 and ANAVEX 1037.

Webull offers Anavex Life Sciences Corp stock information, including NASDAQ: AVXL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVXL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVXL stock methods without spending real money on the virtual paper trading platform.